Furthermore, the efficacy and potential side effects of cell surface ‘patching’ to spatially rearrange and antagonize CXCR4 warrant further investigation using transgenic or humanized animal models that closely recapitulate the development of breast cancer metastasis. This evidence concerns the gene CXCR4 and breast carcinoma.